gip and glp-1 & Agonists | Obesity Diabetes Management | Harrison's updates (22nd Ed.) Dual GIP/GLP-1 receptor agonists: New

Description

Call 1-844-967-3536 Get What Your Injury Is Worth Free case review, and no fee unless we win

Conserved T cell selection by BTNL proteins limits progression of human inflammatory bowel disease

GLP-1 inhibits PKC2 phosphorylation to improve the osteogenic differentiation potential of hPDLSCs in the AGE microenvironment

SMR insights into the causal relationship between GLP-1RA and DR In the SMR analysis between blood GLP-1R target gene expression and DR risk, we visualised the SNP distribution and P -value relationship between the eQTL dataset and the GWAS dataset for DR, where the labelled dots are the instrumental variable top-SNPs (usually those with the smallest P -value in the exposure dataset), and the red line represents P = 0.025, above which indicates significant statistical significance, while the opposite does not suggest a significant cause-and-effect relation between exposure and outcome (Fig